Cellular uptake mechanisms of novel anionic siRNA lipoplexes

Pharmaceutical Research

Volumn 30, Issue 4, 2013, Pages 1161-1175

  Kapoor, Mamta ^a   Burgess, Diane J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

anionic lipoplexes; endocytosis; formulation composition; siRNA; uptake mechanism pathway

Indexed keywords

ACTIN; ANION; CALCIUM ION; HEPARIN; LIPOFECTAMINE; LIPOPLEX; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG ANALYSIS; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG UPTAKE; ENDOCYTOSIS; ENDOSOME; MEMBRANE FUSION; MICROTUBULE; PARTICLE SIZE; PINOCYTOSIS; POLYMERIZATION; PRIORITY JOURNAL; ZETA POTENTIAL;

ACTINS; ANIONS; BREAST; BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; FEMALE; HUMANS; LIPIDS; PINOCYTOSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84876500255     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0952-9     Document Type: Article

References (40)

1. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell. 2008;134(4):577-86.
2. Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61(10):850-62.
3. Wang J, Lu Z, Wientjes M, Au J. Delivery of siRNA Therapeutics: Barriers and Carriers. AAPS J. 2010;12(4):492-503.
4. Kapoor M, Burgess DJ, Patil SD. Physicochemical characterization techniques for lipid based delivery systems for siRNA. Int J Pharm. 2012;427(1):35-57.
5. Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release. 2006;116(2):255-64.
6. Kedmi R, Ben-Arie N, Peer D. The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials. 2010;31(26):6867-75.
7. Patil SD, Rhodes DG, Burgess DJ. Anionic liposomal delivery system for DNA transfection. AAPS J. 2004;6(4):e29.
8. Srinivasan C, Burgess DJ. Optimization and characterization of anionic lipoplexes for gene delivery. J Control Release. 2009;136(1):62-70.
9. Kapoor M, Burgess DJ. Efficient and safe delivery of siRNA using anionic lipids: formulation optimization studies. Int J Pharm. 2012;432(1-2):80-90.
10. Kapoor M, Burgess DJ. Physicochemical characterization of anionic lipid-based ternary siRNA complexes. Biochim et Biophys Acta (BBA) - Biomembr. 2012;1818(7):1603-12.
11. Khalil IA, Kogure K, Akita H, Harashima H. Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery. Pharmacol Rev. 2006;58(1):32-45.
12. Lu JJ, Langer R, Chen J. A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol Pharm. 2009;6(3):763-71.
13. Bentz J. Intermediates and kinetics of membrane fusion. Biophys J. 1992;63(2):448-59.
14. Punnonen EL, Ryhanen K, Marjomaki VS. At reduced temperature, endocytic membrane traffic is blocked in multivesicular carrier endosomes in rat cardiac myocytes. Eur J Cell Biol. 1998;75(4):344-52.
15. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release. 2010;145(3):182-95.
16. Payne CK, Jones SA, Chen C, Zhuang X. Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic. 2007;8(4):389-401.
17. Rejman J, Bragonzi A, Conese M. Role of Clathrin- and Caveolae-Mediated Endocytosis in Gene Transfer Mediated by Lipo- and Polyplexes. Mol Ther. 2005;12(3):468-74.
18. Bolte S, Cordelieres FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224(Pt 3):213-32.
19. Abbineni G, Modali S, Safiejko-Mroczka B, Petrenko VA, Mao C. Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization. Mol Pharm. 2010;7(5):1620-42.
20. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol. 1998;141(4):905-15.
21. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol. 2010;188(4):547-63.
22. Maniak M. Macropinocytosis. In: Marsh M, editor. Endocytosis, vol. 1. Great Britain: Oxford University Press; 2001. p. 78-87.
23. Casella JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature. 1981;293(5830):302-5.
24. Zieve GW, Turnbull D, Mullins JM, McIntosh JR. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor Nocodazole: Nocodazole accumulated mitotic cells. Exp Cell Res. 1980;126(2):397-405.
25. Chernomordik LV, Zimmerberg J. Bending membranes to the task: structural intermediates in bilayer fusion. Curr Opin Struct Biol. 1995;5(4):541-7.
26. Noguchi A, Furuno T, Kawaura C, Nakanishi M. Membrane fusion plays an important role in gene transfection mediated by cationic liposomes. FEBS Lett. 1998;433(1-2):169-73.
27. Delehedde M, Deudon E, Boilly B, Hondermarck H. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells. Exp Cell Res. 1996;229(2):398-406.
28. Garud DR, Tran VM, Victor XV, Koketsu M, Kuberan B. Inhibition of heparan sulfate and chondroitin sulfate proteoglycan biosynthesis. J Biol Chem. 2008;283(43):28881-7.
29. Nakase I, Niwa M, Takeuchi T, Sonomura K, Kawabata N, Koike Y, et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther. 2004;10(6):1011-22.
30. Waterman-Storer CM, Worthylake RA, Liu BP, Burridge K, Salmon ED. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat Cell Biol. 1999;1(1):45-50.
31. Swanson JA, Johnson MT, Beningo K, Post P, Mooseker M, Araki N. A contractile activity that closes phagosomes in macrophages. J Cell Sci. 1999;112(Pt 3):307-16.
32. Swanson JA. Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol. 2008;9(8):639-49.
33. Caron E, Hall A. Phagocytosis. In: Marsh M, editor. Endocytosis, vol. 1. Great Britain: Oxford University Press; 2001. p. 58-71.
34. Schagat TL, Tino MJ, Wright JR. Regulation of protein phosphorylation and pathogen phagocytosis by surfactant protein A. Infect Immun. 1999;67(9):4693-9.
35. Isenberg G. Actin binding proteins-lipid interactions. J Muscle Res Cell Motil. 1991;12(2):136-44.
36. Schmidt SM, Moran KA, Tweed Kent AM, Slosar JL, Webber MJ, McCready MJ, et al. Uptake of calcium phosphate nanoshells by osteoblasts and their effect on growth and differentiation. Journal of Biomedical Materials Research Part A. 2008;87A:418-28.
37. Tellam R. Mechanism of CaCl2-induced actin polymerization. Biochemistry. 1985;24(16):4455-60.
38. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med. 2004;10(3):310-5.
39. Kulkarni VI, Shenoy VS, Dodiya SS, Rajyaguru TH, Murthy RR. Role of calcium in gene delivery. Expert Opin Drug Deliv. 2006;3(2):235-45.
40. Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev. 2004;56(8):1099-109.